{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:38:04Z","timestamp":1794533884699,"version":"4.9.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013699","name":"Bundesministerium f\u00fcr Bildung Wissenschaft und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009553","name":"Agentura Pro Zdravotnick\u00fd V\u00fdzkum \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR 265"],"award-info":[{"award-number":["TRR 265"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["2020"],"award-info":[{"award-number":["2020"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01ZX1909A"],"award-info":[{"award-number":["01ZX1909A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.neuroscience.2024.09.006","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T12:28:30Z","timestamp":1725366510000},"page":"156-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and mice"],"prefix":"10.1016","volume":"559","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7475-7290","authenticated-orcid":false,"given":"Veronika","family":"Poho\u0159al\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7616-6352","authenticated-orcid":false,"given":"Martin","family":"Kucha\u0159","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Spanagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick E.","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2024.09.006_b0005","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1038\/npp.2016.5","article-title":"Activation of D1\/5 Dopamine Receptors: A Common Mechanism for Enhancing Extinction of Fear and Reward-Seeking Behaviors","volume":"41","author":"Abraham","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0010","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00213-023-06384-w","article-title":"Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memories","volume":"240","author":"Benvenuti","year":"2023","journal-title":"Psychopharmacology (berl)"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fnbeh.2017.00221","article-title":"Dissociable Role of Corticotropin Releasing Hormone Receptor Subtype 1 on Dopaminergic and D1 Dopaminoceptive Neurons in Cocaine Seeking Behavior","volume":"11","author":"Bernardi","year":"2017","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0020","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/WNR.0b013e32835ad246","article-title":"Prazosin differentially affects extinction of cocaine conditioned place preference on the basis of dose and initial preference","volume":"23","author":"Bernardi","year":"2012","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0025","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1523\/JNEUROSCI.1120-18.2019","article-title":"The Inhibition of RasGRF2, But Not RasGRF1, Alters Cocaine Reward in Mice","volume":"39","author":"Bernardi","year":"2019","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.drugalcdep.2013.08.024","article-title":"The ClockDelta19 mutation in mice fails to alter the primary and secondary reinforcing properties of nicotine","volume":"133","author":"Bernardi","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0035","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1037\/a0037020","article-title":"Enhanced extinction of contextual fear conditioning in ClockDelta19 mutant mice","volume":"128","author":"Bernardi","year":"2014","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0040","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nrd.2016.88","article-title":"Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets","volume":"15","author":"Bespalov","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0045","doi-asserted-by":"crossref","first-page":"552","DOI":"10.7334\/psicothema2016.383","article-title":"Non-normal data: Is ANOVA still a valid option?","volume":"29","author":"Blanca","year":"2017","journal-title":"Psicothema"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7334\/psicothema2022.292","article-title":"Non-normal Data in Repeated Measures ANOVA: Impact on Type I Error and Power","volume":"35","author":"Blanca","year":"2023","journal-title":"Psicothema"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0055","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00213-013-3120-y","article-title":"The reinstatement model of drug relapse: Recent neurobiological findings, emerging research topics, and translational research","volume":"229","author":"Bossert","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0065","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.clinpsy.3.022806.091455","article-title":"Relapse and relapse prevention","volume":"3","author":"Brandon","year":"2007","journal-title":"Annu Rev Clin Psychol"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00213-007-0916-7","article-title":"Stimulation of serotonin2C receptors influences cocaine-seeking behavior in response to drug-associated stimuli in rats","volume":"196","author":"Burbassi","year":"2008","journal-title":"Psychopharmacology (berl)"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0075","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.npp.1300346","article-title":"Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats","volume":"29","author":"Burmeister","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0080","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/acschemneuro.8b00134","article-title":"Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression","volume":"9","author":"Cameron","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0085","doi-asserted-by":"crossref","first-page":"7472","DOI":"10.1523\/JNEUROSCI.1384-23.2023","article-title":"Beyond the 5-HT(2A) Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action","volume":"43","author":"Cameron","year":"2023","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0090","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of Psilocybin versus Escitalopram for Depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0095","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00221-013-3579-0","article-title":"Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning","volume":"228","author":"Catlow","year":"2013","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0100","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0105","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0110","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41398-021-01706-y","article-title":"Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder","volume":"11","author":"Doss","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0115","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1097\/CM9.0000000000002647","article-title":"Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity","volume":"136","author":"Du","year":"2023","journal-title":"Chin Med J (engl)"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0120","doi-asserted-by":"crossref","unstructured":"Erkizia-Santamaria I, Alles-Pascual R, Horrillo I, Meana JJ, Ortega JE (2022) Serotonin 5-HT(2A), 5-HT(2c) and 5-HT(1A) receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response. Biomed Pharmacother 154: 113612.","DOI":"10.1016\/j.biopha.2022.113612"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0125","first-page":"35","article-title":"Role of serotonin (5-HT)2 receptors in cocaine self-administration and seeking behavior in rats","volume":"57","author":"Filip","year":"2005","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0130","first-page":"576","article-title":"Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding","volume":"27","author":"Fletcher","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1874473708666150107121331","article-title":"Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction","volume":"7","author":"Garcia-Romeu","year":"2014","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0140","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0269881119845793","article-title":"Cessation and reduction in alcohol consumption and misuse after psychedelic use","volume":"33","author":"Garcia-Romeu","year":"2019","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0145","doi-asserted-by":"crossref","first-page":"12702","DOI":"10.1038\/s41598-022-16325-w","article-title":"Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents","volume":"12","author":"Golden","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0150","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0155","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0165","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2011.01.017","article-title":"Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens","volume":"61","author":"Halberstadt","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0170","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1177\/0269881110388326","article-title":"Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice","volume":"25","author":"Halberstadt","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0175","article-title":"Are \u201cmystical experiences\u201d essential for antidepressant actions of ketamine and the classic psychedelics?","author":"Hashimoto","year":"2024","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0180","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00213-020-05756-w","article-title":"The acute effects of classic psychedelics on memory in humans","volume":"238","author":"Healy","year":"2021","journal-title":"Psychopharmacology (berl)"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0190","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awae136","article-title":"Psilocybin reduces alcohol self-administration via selective left nucleus accumbens activation in rats","author":"Jeanblanc","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0195","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/adb.12483","article-title":"d-Cycloserine enhanced extinction of cocaine-induced conditioned place preference is attenuated in serotonin transporter knockout rats","volume":"23","author":"Karel","year":"2018","journal-title":"Addict Biol"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0200","article-title":"Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala","author":"Kelly","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0205","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1038\/s41380-023-02280-z","article-title":"Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats","volume":"28","author":"Kiilerich","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0210","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fnbeh.2019.00262","article-title":"Understanding Addiction Using Animal Models","volume":"13","author":"Kuhn","year":"2019","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108114","article-title":"The association between quantity, frequency and duration of cocaine use during the heaviest use period and DSM-5 cocaine use disorder","volume":"213","author":"Liu","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0220","doi-asserted-by":"crossref","unstructured":"Lopez-Quintero C, P\u00e9rez de los Cobos J, Hasin DS, Okuda M, Wang S, Grant BF, et al. (2011) Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend 115: 120-30.","DOI":"10.1016\/j.drugalcdep.2010.11.004"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0225","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/02791072.2020.1849879","article-title":"Long-term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-containing Mushrooms","volume":"53","author":"Lugo-Radillo","year":"2021","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0230","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/clc.20746","article-title":"Cocaine and the heart","volume":"33","author":"Maraj","year":"2010","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0235","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0028-3908(90)90001-8","article-title":"Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes","volume":"29","author":"McKenna","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0240","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/s41386-020-0694-z","article-title":"Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse","volume":"45","author":"Meinhardt","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0245","doi-asserted-by":"crossref","first-page":"eabh2399","DOI":"10.1126\/sciadv.abh2399","article-title":"Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism","volume":"7","author":"Meinhardt","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.986566","article-title":"Nicotine self-administration and ERK signaling are altered in RasGRF2 knockout mice","volume":"13","author":"Morella","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0255","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0260","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbr.2014.04.007","article-title":"The role of serotonin in drug use and addiction","volume":"277","author":"Muller","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0265","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/FBP.0b013e3282f1c94b","article-title":"Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats","volume":"18","author":"Neisewander","year":"2007","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0270","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1037\/a0014592","article-title":"Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model","volume":"123","author":"Nic Dhonnchadha","year":"2009","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0275","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/npp.2009.139","article-title":"D-cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning","volume":"35","author":"Nic Dhonnchadha","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0280","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.17111","article-title":"Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors","volume":"5","author":"Papale","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0285","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/1355621021000005937","article-title":"The pharmacology of psilocybin","volume":"7","author":"Passie","year":"2002","journal-title":"Addict Biol"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0290","doi-asserted-by":"crossref","first-page":"278","DOI":"10.20882\/adicciones.862","article-title":"Modelos animales de adicci\u00f3n a las drogas Animal Models of Drug Addiction","volume":"29","author":"Pilar Garc\u00eda Pardo","year":"2017","journal-title":"Adicciones"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0295","doi-asserted-by":"crossref","unstructured":"Pohorala V, Enkel T, Bartsch D, Spanagel R, Bernardi RE (2021) Sign- and goal-tracking score does not correlate with addiction-like behavior following prolonged cocaine self-administration. Psychopharmacology (Berl).","DOI":"10.1007\/s00213-021-05858-z"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0300","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fnbeh.2014.00180","article-title":"The effect of psilocin on memory acquisition, retrieval, and consolidation in the rat","volume":"8","author":"Rambousek","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0305","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.2174\/092986712803988893","article-title":"Side effects of cocaine abuse: multiorgan toxicity and pathological consequences","volume":"19","author":"Riezzo","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0310","doi-asserted-by":"crossref","unstructured":"Rogers SA, Heller EA, Corder G (2024) Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles. bioRxiv.","DOI":"10.1101\/2024.02.04.578811"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0315","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1369-1600.2006.00012.x","article-title":"Behavioural assessment of drug reinforcement and addictive features in rodents: An overview","volume":"11","author":"Sanchis-Segura","year":"2006","journal-title":"Addiction Biology"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0320","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0091-3057(00)00377-4","article-title":"Effects of the serotonin 5-HT(2) antagonist, ritanserin, and the serotonin 5-HT(1A) antagonist, WAY 100635, on cocaine-seeking in rats","volume":"67","author":"Schenk","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0325","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/SAR.S337338","article-title":"Cocaine Use Disorder (CUD): Current Clinical Perspectives","volume":"13","author":"Schwartz","year":"2022","journal-title":"Subst Abuse Rehabil"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0330","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/02791072.2023.2190319","article-title":"Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review","volume":"55","author":"Sharma","year":"2023","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0335","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/jnc.15540","article-title":"Molecular insights into psychedelic drug action","volume":"162","author":"Slocum","year":"2022","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0340","doi-asserted-by":"crossref","first-page":"247","DOI":"10.31887\/DCNS.2017.19.3\/rspanagel","article-title":"Animal models of addiction","volume":"19","author":"Spanagel","year":"2017","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0345","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.neubiorev.2013.07.003","article-title":"Characterizing the cognitive effects of cocaine: a comprehensive review","volume":"37","author":"Spronk","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0350","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/syn.20922","article-title":"D-cycloserine facilitates extinction of cocaine self-administration in rats","volume":"65","author":"Thanos","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0355","doi-asserted-by":"crossref","first-page":"1156319","DOI":"10.3389\/fnins.2023.1156319","article-title":"Mini-review: The neurobiology of treating substance use disorders with classical psychedelics","volume":"17","author":"Urban","year":"2023","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0360","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/cns.14054","article-title":"Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling","volume":"29","author":"Wang","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0365","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126713","article-title":"Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior","volume":"23","author":"Wojtas","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0370","first-page":"25","article-title":"Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study","author":"Wojtas","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0375","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.4c00279","article-title":"Psilocybin Facilitates Fear Extinction: Importance of Dose","author":"Woodburn","year":"2024","journal-title":"Context, and Serotonin Receptors. ACS Chem Neurosci."},{"key":"10.1016\/j.neuroscience.2024.09.006_b0380","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","article-title":"The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects","volume":"4","author":"Yaden","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.neuroscience.2024.09.006_b0385","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.neuropharm.2012.06.007","article-title":"Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL\/6J mice","volume":"64","author":"Zhang","year":"2013","journal-title":"Neuropharmacology"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224004512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224004512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:56:23Z","timestamp":1778745383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452224004512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":76,"alternative-id":["S0306452224004512"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.09.006","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and mice","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}